Global Type 1 Diabetes (T1D) Market: Industry Analysis and Forecast (2020-2026) by Product Type, Application, and Region

Global Type 1 Diabetes (T1D) Market is expected to grow at a CAGR of 17.2% during the forecast period. Global Type 1 Diabetes (T1D) Market is expected to reach US$ 24 Bn. by 2026. The global Type 1 Diabetes (T1D) market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Type 1 Diabetes (T1D) report also provides trends by market segments, technology, and investment with a competitive landscape. Global Type 1 Diabetes (T1D) Market To know about the Research Methodology :- Request Free Sample Report

Global Type 1 Diabetes (T1D) Market Overview:

Diabetes is a set of metabolic diseases marked by elevated blood sugar levels. Diabetes is caused by insufficient insulin production in the pancreas. Frequent urination, excessive thirst, increased hunger, weight loss, and tiredness are all common diabetes symptoms. Type 1 diabetes is more frequent in children and young people than type 2 diabetes. Type 1 diabetes (T1D), which is treated using a variety of insulin delivery devices and medicines, is now one of the most common chronic illnesses in the world.

Global Type 1 Diabetes (T1D) Market Dynamics:

Drivers:

Owing to the expanding number of chronic illnesses linked to diabetes, there has been a surge in the usage of insulin delivery devices recently. Some of the important reasons driving the growth of the global type 1 diabetes market include increased public awareness and technological advancements in insulin delivery devices. Furthermore, rising government measures to combat diabetes are fueling the worldwide type 1 diabetes market's expansion. Diabetes control and awareness programs sponsored by several governments and private organizations are expected to boost the market growth. Moreover, the development of non-invasive diabetes diagnostics and medication delivery technologies would create a potential for the worldwide type 1 diabetes market to flourish. The worldwide type 1 diabetes market is expected to develop due to rising demand for the artificial pancreas and home infusion therapy for diabetic treatment.

Restraints:

The introduction of biosimilars, on the other hand, may limit the growth of the type 1 diabetes therapy market. Furthermore, in developing countries, high-cost diagnosis and treatment will continue to be a barrier to market penetration. Inadequate reimbursement regulations are also expected to limit industry expansion in the coming years. Adoption rates might also be hampered by negative effects.

Global Type 1 Diabetes (T1D) Market Segment Analysis:

Based on the Application, the Children segment has dominated the market during the forecast period. Type 1 diabetes is most commonly found in children and young adults, although it can strike anybody at any age. People with Type 1 diabetes are often slim to normal weight, and they frequently lose weight before being diagnosed. According to the CDC, type 1 diabetes affects less than 10% of people. While genetics and some viruses may have a role in the disease's development, the actual etiology is unknown. Global Type 1 Diabetes (T1D) Market 1

Global Type 1 Diabetes (T1D) Market Regional Insights:

North America presently dominates the worldwide type 1 diabetes market, and it is expected to remain so for the foreseeable future. The rapid increase in type 1 diabetes cases in North America, as well as the region's sophisticated healthcare infrastructure to tackle the disease's prevalence, will help to drive the market for type 1 diabetes therapy in this area. Even though diabetes treatment and medicines are more expensive in the United States than in other industrialized countries, the United States is expected to remain the leading market for type 1 diabetes in the next years. By the end of 2026, APAC is predicted to have seen significant growth in the coming years. Diabetes occurrences are on the rise, as is the elderly population, and life expectancy is increasing in this area, particularly in Japan, China, and India. Aside from the United States and Japan, important markets for type 1 diabetes will continue to include the United Kingdom, Canada, France, Germany, Spain, and Italy. In the next years, growth in the Middle East and Africa will be slower. Global Type 1 Diabetes (T1D) Market 2 The objective of the report is to present a comprehensive analysis of the global Type 1 Diabetes (T1D) market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the global Type 1 Diabetes (T1D) market dynamics, structure by analyzing the market segments and project the global Type 1 Diabetes (T1D) market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global Type 1 Diabetes (T1D) market makes the report investor’s guide.

Global Type 1 Diabetes (T1D) Market Scope: Inquire before buying

Global Type 1 Diabetes (T1D) Market 3

Global Type 1 Diabetes (T1D) Market, by Region

• North America • Europe • Asia Pacific • The Middle East and Africa • South America

Global Type 1 Diabetes (T1D) Market Key Players

• Novo Nordisk • Sanofi • Eli Lilly and Company • Merck • Boehringer Ingelheim International GmbH • Samsung Bioepis • Biocon • Astellas • Janssen • Bristol-Myers Squibb • Lexicon • AstraZeneca Plc • B. Braun Melsungen AG • DiaVacs Inc • XOMA Corp • Biodel Inc • Macrogenics Inc • Wockhardt • Other Key Players
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Type 1 Diabetes (T1D) Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Type 1 Diabetes (T1D) Market 3.4. Geographical Snapshot of the Type 1 Diabetes (T1D) Market, By Manufacturer share 4. Global Type 1 Diabetes (T1D) Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Type 1 Diabetes (T1D) Market 5. Supply Side and Demand Side Indicators 6. Global Type 1 Diabetes (T1D) Market Analysis and Forecast, 2019-2026 6.1. Global Type 1 Diabetes (T1D) Market Size & Y-o-Y Growth Analysis. 7. Global Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 7.1.1. Rapid Acting Insulin Analogs 7.1.2. Long-Acting Insulin Analogs 7.1.3. Premix Insulin Analogs 7.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 7.2.1. Childrens 7.2.2. Adults 8. Global Type 1 Diabetes (T1D) Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 9.1.1. Rapid Acting Insulin Analogs 9.1.2. Long-Acting Insulin Analogs 9.1.3. Premix Insulin Analogs 9.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 9.2.1. Childrens 9.2.2. Adults 10. North America Type 1 Diabetes (T1D) Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 12. Canada Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 13. Mexico Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 14. Europe Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 15. Europe Type 1 Diabetes (T1D) Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 17. France Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 18. Germany Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 19. Italy Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 20. Spain Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 21. Sweden Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 22. CIS Countries Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 23. Rest of Europe Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 24. Asia Pacific Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 25. Asia Pacific Type 1 Diabetes (T1D) Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 27. India Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 28. Japan Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 29. South Korea Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 30. Australia Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 31. ASEAN Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 32. Rest of Asia Pacific Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 33. Middle East Africa Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 34. Middle East Africa Type 1 Diabetes (T1D) Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 36. GCC Countries Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 37. Egypt Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 38. Nigeria Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 39. Rest of ME&A Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 40. South America Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 41. South America Type 1 Diabetes (T1D) Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 43. Argentina Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 44. Rest of South America Type 1 Diabetes (T1D) Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Product Type, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Type 1 Diabetes (T1D) Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Novo Nordisk 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Sanofi 45.3.3. Eli Lilly and Company 45.3.4. Merck 45.3.5. Boehringer Ingelheim International GmbH 45.3.6. Samsung Bioepis 45.3.7. Biocon 45.3.8. Astellas 45.3.9. Janssen 45.3.10. Bristol-Myers Squibb 45.3.11. Lexicon 45.3.12. AstraZeneca Plc 45.3.13. B. Braun Melsungen AG 45.3.14. DiaVacs Inc 45.3.15. XOMA Corp 45.3.16. Biodel Inc 45.3.17. Macrogenics Inc 45.3.18. Wockhardt 45.3.19. Other Key Players 46. Primary Key Insights

About This Report

Report ID 103859
Category Healthcare
Published Date May 2021
Updated Date
Contact Us